Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA3 | P07451 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA6 | P23280 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.33 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.30 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.30 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.30 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.30 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8653932 | 0.82 | CHRM1 (0.41) | GRIK1SLC1A3SLC1A2SLC1A1GRIK2 | |
| SCHEMBL6538570 | 0.77 | CYP1A2 (0.34) | LMNACA12CA1CA2CA3 | |
| Piperazine SCHEMBL28303242 | 0.76 | GRIK1 (0.34) | GRIK1SLC1A3SLC1A2SLC1A1GRIK2 | |
| SCHEMBL4336795 | 0.75 | — | — | |
| SCHEMBL9241060 | 0.72 | GRIK1 (0.34) | GRIK1SLC1A3SLC1A2SLC1A1GRIK2 | |
| Norleucine SCHEMBL28577914 | 0.72 | DDAH1 (0.48) | GRIK1SLC1A3SLC1A2SLC1A1GRIK2 | |
| SCHEMBL8079895 | 0.69 | GRIK1 (0.32) | GRIK1SLC1A3SLC1A2SLC1A1GRIK2 | |
| Propionic Acid SCHEMBL1518988 | 0.68 | FFAR3 (0.48) | LMNACA12CA1CA2CA3 | |
| Pivalate SCHEMBL10534446 | 0.68 | POLB (0.34) | CA12CA1CA9 | |
| SCHEMBL27734622 | 0.68 | GRIK1 (0.47) | GRIK1SLC1A2SLC1A1GRIK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010006814-A1 | Chemical modification | ENZO BIOCHEM, INC. | 2001-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010006814-A1 | Chemical modification | RNASE1, DNASE1L3, DNASE1 | LMNA 551/4885CA12 2186/4885CA1 2130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.